Bogyo M, Upadhyay T, Woods E, Ahator S, Julin K, Faucher F
Res Sq. 2024; .
PMID: 39711551
PMC: 11661381.
DOI: 10.21203/rs.3.rs-5494070/v1.
Zou M, Zhang Y, Du C, Yang B, Guo P, Liang H
Mol Neurobiol. 2024; 62(4):5022-5038.
PMID: 39503811
DOI: 10.1007/s12035-024-04606-6.
Zhu D, Zhang J, Ma X, Hu M, Gao F, Hashem J
bioRxiv. 2024; .
PMID: 39345517
PMC: 11430108.
DOI: 10.1101/2024.09.17.613513.
Di Meo C, Tortolani D, Standoli S, Ciaramellano F, Angelucci B, Tisi A
Biofactors. 2024; 51(1):e2122.
PMID: 39275884
PMC: 11681214.
DOI: 10.1002/biof.2122.
Briand-Mesange F, Gennero I, Salles J, Trudel S, Dahan L, Ausseil J
Molecules. 2024; 29(15).
PMID: 39125098
PMC: 11314389.
DOI: 10.3390/molecules29153694.
Endocannabinoid Receptor 2 Function is Associated with Tumor-Associated Macrophage Accumulation and Increases in T Cell Number to Initiate a Potent Antitumor Response in a Syngeneic Murine Model of Glioblastoma.
Duan J, Chen J, Lin Y, Lin S, Wu J
Cannabis Cannabinoid Res. 2024; 9(6):1524-1536.
PMID: 38888628
PMC: 11685299.
DOI: 10.1089/can.2024.0063.
Presynaptic nanoscale components of retrograde synaptic signaling.
Barti B, Dudok B, Kenesei K, Zoldi M, Miczan V, Balla G
Sci Adv. 2024; 10(22):eado0077.
PMID: 38809980
PMC: 11135421.
DOI: 10.1126/sciadv.ado0077.
Astrocytic Deletion Decreases Hedonic Feeding in Female Mice.
Leidmaa E, Prodan A, Depner L, Komorowska-Muller J, Beins E, Schuermann B
Cannabis Cannabinoid Res. 2024; 9(1):74-88.
PMID: 38265773
PMC: 10874831.
DOI: 10.1089/can.2023.0194.
Endocannabinoid biosynthetic enzymes regulate pain response via LKB1-AMPK signaling.
Chen M, Shin M, Ware T, Donvito G, Muchhala K, Mischel R
Proc Natl Acad Sci U S A. 2023; 120(52):e2304900120.
PMID: 38109529
PMC: 10756258.
DOI: 10.1073/pnas.2304900120.
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years.
Maccarrone M, Di Marzo V, Gertsch J, Grether U, Howlett A, Hua T
Pharmacol Rev. 2023; 75(5):885-958.
PMID: 37164640
PMC: 10441647.
DOI: 10.1124/pharmrev.122.000600.
Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases.
Chen C
Pharmacol Ther. 2023; 244:108394.
PMID: 36966972
PMC: 10123871.
DOI: 10.1016/j.pharmthera.2023.108394.
Inhibition of diacylglycerol lipase β modulates lipid and endocannabinoid levels in the human placenta.
Berger N, van der Wel T, Hirschmugl B, Baernthaler T, Gindlhuber J, Fawzy N
Front Endocrinol (Lausanne). 2023; 14:1092024.
PMID: 36864832
PMC: 9971001.
DOI: 10.3389/fendo.2023.1092024.
Inhibition of 2-arachidonoylglycerol degradation enhances glial immunity by single-cell transcriptomic analysis.
Zhu D, Zhang J, Hashem J, Gao F, Chen C
J Neuroinflammation. 2023; 20(1):17.
PMID: 36717883
PMC: 9885699.
DOI: 10.1186/s12974-023-02701-4.
Augmentation of 2-arachidonoylglycerol signaling in astrocytes maintains synaptic functionality by regulation of miRNA-30b.
Zhu D, Zhang J, Gao F, Hu M, Hashem J, Chen C
Exp Neurol. 2022; 361:114292.
PMID: 36481187
PMC: 9892245.
DOI: 10.1016/j.expneurol.2022.114292.
Endocannabinoid signaling in the central nervous system.
Martinez Ramirez C, Ruiz-Perez G, Stollenwerk T, Behlke C, Doherty A, Hillard C
Glia. 2022; 71(1):5-35.
PMID: 36308424
PMC: 10167744.
DOI: 10.1002/glia.24280.
Chemical Probes to Control and Visualize Lipid Metabolism in the Brain.
Punt J, van der Vliet D, van der Stelt M
Acc Chem Res. 2022; 55(22):3205-3217.
PMID: 36283077
PMC: 9670861.
DOI: 10.1021/acs.accounts.2c00521.
Endocannabinoid signaling in astrocytes.
Eraso-Pichot A, Pouvreau S, Olivera-Pinto A, Gomez-Sotres P, Skupio U, Marsicano G
Glia. 2022; 71(1):44-59.
PMID: 35822691
PMC: 9796923.
DOI: 10.1002/glia.24246.
Serine Hydrolases in Lipid Homeostasis of the Placenta-Targets for Placental Function?.
Berger N, Allerkamp H, Wadsack C
Int J Mol Sci. 2022; 23(12).
PMID: 35743292
PMC: 9223866.
DOI: 10.3390/ijms23126851.
Genes Responsible for HS Production and Metabolism Are Involved in Learning and Memory in .
Zatsepina O, Chuvakova L, Nikitina E, Rezvykh A, Zakluta A, Sarantseva S
Biomolecules. 2022; 12(6).
PMID: 35740876
PMC: 9221306.
DOI: 10.3390/biom12060751.
Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome.
Bainbridge M, Mazumder A, Ogasawara D, Abou Jamra R, Bernard G, Bertini E
Brain. 2022; 145(10):3383-3390.
PMID: 35737950
PMC: 9586540.
DOI: 10.1093/brain/awac223.